North China Pharmaceutical Company.Ltd (SHA:600812)

China · Delayed Price · Currency is CNY

5.14

+0.08 (1.58%)

Aug 20, 2026, 3:00 PM CST

-22.24% (1Y)

Market Cap	8.82B -22.2%
Revenue (ttm)	8.82B -10.8%
Net Income	161.04M -3.2%
EPS	0.09 -2.3%
Shares Out	1.72B
PE Ratio	54.59
Forward PE	n/a
Dividend	0.04 (0.69%)
Ex-Dividend Date	Jun 11, 2026

Volume	29,397,277
Open	5.06
Previous Close	5.06
Day's Range	5.06 - 5.19
52-Week Range	4.11 - 6.78
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 22, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd wa... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 9,972

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600812

Full Company Profile

Financial Performance

In 2025, SHA:600812's revenue was 9.24 billion, a decrease of -6.36% compared to the previous year's 9.87 billion. Earnings were 183.06 million, an increase of 44.15%.

Financial Statements